Cargando…
Systems medicine advances in interstitial lung disease
Fibrotic lung diseases involve subject–environment interactions, together with dysregulated homeostatic processes, impaired DNA repair and distorted immune functions. Systems medicine-based approaches are used to analyse diseases in a holistic manner, by integrating systems biology platforms along w...
Autores principales: | Greiffo, Flavia R., Eickelberg, Oliver, Fernandez, Isis E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488840/ https://www.ncbi.nlm.nih.gov/pubmed/28954764 http://dx.doi.org/10.1183/16000617.0021-2017 |
Ejemplares similares
-
The Notch ligand DNER regulates macrophage IFNγ release in chronic obstructive pulmonary disease
por: Ballester-López, Carolina, et al.
Publicado: (2019) -
Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in interstitial lung disease
por: Schamberger, Andrea C., et al.
Publicado: (2016) -
An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics
por: Angelidis, Ilias, et al.
Publicado: (2019) -
From arginine methylation to ADMA: A novel mechanism with therapeutic potential in chronic lung diseases
por: Zakrzewicz, Dariusz, et al.
Publicado: (2009) -
Predictors of progression in systemic sclerosis patients with interstitial lung disease
por: Distler, Oliver, et al.
Publicado: (2020)